Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 7.
doi: 10.1007/s11606-025-09835-6. Online ahead of print.

Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium

Ethan A Halm  1 , Natalie J Del Vecchio  2 , Katharine A Rendle  3 , Jasmin A Tiro  4 , Yingye Zheng  2 , Rachel L Winer  5 , Jennifer S Haas  6 , Douglas A Corley  7 , Celette Sugg Skinner  8 , Joanne Schottinger  9 , Nirupa R Ghai  9 , Jessica Chubak  10
Affiliations

Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium

Ethan A Halm et al. J Gen Intern Med. .

Abstract

Background: Effective screening for colorectal, cervical, and lung cancer requires adherence over time, but little is known about repeat testing in real-world practice.

Objective: Describe patterns of longitudinal screening adherence and identify patient and system factors associated with repeat testing.

Design: Retrospective cohort study of colorectal, cervical, or lung cancer screening in 2010-2019.

Participants: Adults eligible for repeat colorectal (stool-based), cervical, or lung cancer screening following a negative index test in ten regional health systems comprising the US PROSPR consortium.

Main measures: Repeat screening based on guideline-recommended intervals. For the colorectal and lung cohorts with opportunities for multiple annual screening rounds, the main outcome was repeat screening categorized as none, inconsistent, or consistent.

Results: The sample size was: 1,566,346 for colorectal, 216,344 for cervical, and 6,209 for lung cancer screening. For colorectal, cervical, and lung screeners, mean age at index was 58.2, 39.4, and 64.6 years, respectively, and 49%, 55% and 30% were Hispanic and/or non-white. Completion of the next screening round was 62% for colorectal, 56% for cervical, and 56% for lung cancer. For colorectal, over the next two rounds of testing, 53% were consistent, 33% inconsistent, and 14% no repeat screeners. The comparable percentages over 3 + rounds for colorectal were 40% consistent, 50% inconsistent, and 11% no repeat screeners. For lung, over the next two rounds, 47% were consistent, 31% inconsistent, and 22% no repeat screeners. The proportions over 3 + rounds for lung were 44% consistent, 42% inconsistent, and 14% no repeat screening. The health system was the strongest predictor of repeat and consistent testing with three- to ten-fold variation.

Conclusions: Adherence to longitudinal screening for colorectal, cervical and lung cancer was suboptimal, particularly as the number of testing rounds increased. System-level strategies are needed to increase screening adherence given the strong relationship between health system and outcomes.

Keywords: cervical cancer; colorectal cancer; lung cancer; screening adherence.

PubMed Disclaimer

Conflict of interest statement

Declarations:. Conflict of Interest:: There are no conflicts of interest to report.

References

REFERENCES

    1. Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. Jun 21 2016;315(23):2564-2575. https://doi.org/10.1001/JAMA.2016.5989 - DOI - PubMed
    1. Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. Aug 21 2018;320(7):674-686. https://doi.org/10.1001/JAMA.2018.10897 - DOI - PubMed
    1. Moyer VA. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. Mar 4 2014;160(5):330-8. https://doi.org/10.7326/m13-2771
    1. Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer. May 1 2016;122(9):1338-42. https://doi.org/10.1002/cncr.29937 - DOI - PubMed
    1. Barlow WE, Beaber EF, Geller BM, et al. Evaluating screening participation, follow-up, and outcomes for breast, cervical, and colorectal cancer in the PROSPR consortium. J Natl Cancer Inst. Mar 1 2020;112(3):238-246. https://doi.org/10.1093/jnci/djz137 - DOI - PubMed

LinkOut - more resources